3M’s Tegaderm CHG IV dressing is first transparent dressing indicated to reduce CRBSI


“Global technology company 3M announced today its Tegaderm CHG (chlorhexidine gluconate) I.V. securement dressing is the first transparent antimicrobial dressing to be clinically proven and indicated to reduce catheter-related bloodstream infections (CRBSIs).

Its performance has been validated following an extensive randomised controlled trial led by renowned clinician Professor Jean-François Timsit, President of L’association OutcomeRéa*. Study data was reviewed by the UK Medicines and Healthcare products Regulatory Agency and CE mark certification awarded by the British Standards Institution.”

Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).

Main page


Comments are closed.